FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:383-389 August 5, 1993 Number 6 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The efficacy of thrombolytic therapy for acute myocardial infarction depends partly on how soon after the onset of symptoms it is administered. We therefore studied the efficacy and safety of thrombolytic therapy administered before hospital admission and thrombolytic therapy administered after admission in patients with suspected myocardial infarction.

Methods In a multicenter, double-blind study, patients seen within six hours of the onset of symptoms who had a qualifying 12-lead electrocardiogram were randomly assigned to receive either anistreplase before admission, followed by placebo in the hospital (prehospital group), or placebo before admission, followed by anistreplase in the hospital (hospital group). Prehospital therapy was administered by emergency medical personnel.

Results A total of 2750 patients were randomly assigned to the prehospital group, and 2719 to the hospital group. The patients in the prehospital group received thrombolytic therapy a median of 55 minutes earlier than those in the hospital group. We observed a nonsignificant reduction in overall mortality at 30 days in the prehospital group (9.7 percent vs. 11.1 percent in the hospital group; reduction in risk, 13 percent; 95 percent confidence interval, -1 to 26 percent; P = 0.08). Death from cardiac causes was significantly less frequent in the prehospital group than in the hospital group (8.3 percent vs. 9.8 percent; reduction in risk, 16 percent; 95 percent confidence interval, 0 to 29 percent; P = 0.049). Particular adverse events occurred more frequently in the prehospital group during the period before hospitalization; among these events were ventricular fibrillation (P = 0.02), shock (P<0.001), symptomatic hypotension (P<0.001), and symptomatic bradycardia (P = 0.001). With the exception of symptomatic hypotension, however, the overall incidence of these events was similar for both groups.

Conclusions Prehospital thrombolytic therapy for patients with suspected myocardial infarction is both feasible and safe when administered by well-equipped, well-trained mobile emergency medical staff. Although such therapy appears to reduce mortality from cardiac causes, our data do not definitely establish that it reduces overall mortality.

Source Information

Preliminary results were presented in part at the Scientific Sessions of the American College of Cardiology, Dallas, April 12-16, 1992.This report was prepared by A. Leizorovicz, J.P. Boissel, D. Julian, A. Castaigne, and M.C. Haugh. The members of the European Myocardial Infarction Project (EMIP) Group are listed in the Appendix.

Address reprint requests to the EMIP Group, Unite de Pharmacologie Clinique, B.P. 3041, 69394 Lyon CEDEX 03, France.

Full Text of this Article

Related Letters:

Prehospital Thrombolytic Therapy for Myocardial Infarction
Fath-Ordoubadi F., Solomon S. D., Antman E.
Extract | Full Text  
N Engl J Med 1994; 330:290-291, Jan 27, 1994. Correspondence

This article has been cited by other articles:

• McLean, S, Egan, G, Connor, P, Flapan, A D (2008). Collaborative decision-making between paramedics and CCU nurses based on 12-lead ECG telemetry expedites the delivery of thrombolysis in ST elevation myocardial infarction. Emerg. Med. J. 25: 370-374 [Abstract] [Full Text]  
• Goodman, S. G., Menon, V., Cannon, C. P., Steg, G., Ohman, E. M., Harrington, R. A. (2008). Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 708S-775S [Abstract] [Full Text]  
• Boden, W. E., Eagle, K., Granger, C. B. (2007). Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management Options. J Am Coll Cardiol 50: 917-929 [Abstract] [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]  
• Yang, Y., Zhu, W.-Z., Joiner, M.-l., Zhang, R., Oddis, C. V., Hou, Y., Yang, J., Price, E. E., Gleaves, L., Eren, M., Ni, G., Vaughan, D. E., Xiao, R.-P., Anderson, M. E. (2006). Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am. J. Physiol. Heart Circ. Physiol. 291: H3065-H3075 [Abstract] [Full Text]  
• McNamara, R. L., Wang, Y., Herrin, J., Curtis, J. P., Bradley, E. H., Magid, D. J., Peterson, E. D., Blaney, M., Frederick, P. D., Krumholz, H. M., for the NRMI Investigators, (2006). Effect of Door-to-Balloon Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol 47: 2180-2186 [Abstract] [Full Text]  
• Castle, N, Owen, R, Vincent, R, Ineson, N (2006). What percentages of patients are suitable for prehospital thrombolysis?. Emerg. Med. J. 23: 444-445 [Abstract] [Full Text]  
• Danchin, N. (2006). Should intravenous thrombolysis keep a place in the treatment of acute ST-elevation myocardial infarction?. Eur Heart J 27: 1131-1133 [Full Text]  
• Bjorklund, E., Stenestrand, U., Lindback, J., Svensson, L., Wallentin, L., Lindahl, B., on behalf of the RIKS-HIA Investigators, (2006). Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J 27: 1146-1152 [Abstract] [Full Text]  
• (2005). Part 8: Stabilization of the Patient With Acute Coronary Syndromes. Circulation 112: IV-89-IV-110 [Full Text]  
• de Belder, A (2005). Should primary angioplasty be available for all patients with an ST elevation myocardial infarction?. Heart 91: 1509-1511 [Abstract] [Full Text]  
• Huber, K., Caterina, R. D., Kristensen, S. D., Verheugt, F. W.A., Montalescot, G., Maestro, L. B., Werf, F. V. d., for the Task Force on Pre-hospital Reperfusion The, (2005). Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J 26: 2063-2074 [Full Text]  
• Thiele, H., Engelmann, L., Elsner, K., Kappl, M. J., Storch, W.-H., Rahimi, K., Hartmann, A., Pfeiffer, D., Kneissl, G. D., Schneider, D., Moller, T., Heberling, H. J., Weise, I., Schuler, G., for the Leipzig Prehospital Fibrinolysis Group, (2005). Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 26: 1956-1963 [Abstract] [Full Text]  
• Bonnefoy, E., Steg, P. G., Chabaud, S., Dubien, P.-Y., Lapostolle, F., Boudet, F., Lacroute, J.-M., Dissait, F., Vanzetto, G., Leizorowicz, A., Touboul, P., for the CAPTIM investigators, (2005). Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial. Eur Heart J 26: 1712-1718 [Abstract] [Full Text]  
• Chittari, M S V M, Ahmad, I, Chambers, B, Knight, F, Scriven, A, Pitcher, D (2005). Retrospective observational case-control study comparing prehospital thrombolytic therapy for ST-elevation myocardial infarction with in-hospital thrombolytic therapy for patients from same area. Emerg. Med. J. 22: 582-585 [Abstract] [Full Text]  
• Schofield, P M (2005). Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention. Heart 91: iii7-iii11 [Full Text]  
• Terkelsen, C. J., Lassen, J. F., Norgaard, B. L., Gerdes, J. C., Poulsen, S. H., Bendix, K., Ankersen, J. P., Gotzsche, L. B.-H., Romer, F. K., Nielsen, T. T., Andersen, H. R. (2005). Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention. Eur Heart J 26: 770-777 [Abstract] [Full Text]  
• Machecourt, J., Bonnefoy, E., Vanzetto, G., Motreff, P., Marliere, S., Leizorovicz, A., Allenet, B., Lacroute, J. M., Cassagnes, J., Touboul, P. (2005). Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center: The Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study. J Am Coll Cardiol 45: 515-524 [Abstract] [Full Text]  
• Hanefeld, C., Sirtl, C., Spiecker, M., Bojara, W., Grewe, P. H., Lawo, T., Mugge, A. (2004). Prehospital Therapy With the Platelet Glycoprotein IIb/IIIa Inhibitor Eptifibatide in Patients With Suspected Acute Coronary Syndromes: The Bochum Feasibility Study. Chest 126: 935-941 [Abstract] [Full Text]  
• Goodacre, S, Kelly, A-M, Kerr, D (2004). Potential impact of interventions to reduce times to thrombolysis. Emerg. Med. J. 21: 625-629 [Abstract] [Full Text]  
• Menon, V., Harrington, R. A., Hochman, J. S., Cannon, C. P., Goodman, S. D., Wilcox, R. G., Schunemann, H. J., Ohman, E. M. (2004). Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 549S-575S [Abstract] [Full Text]  
• Kroese, M., Kanka, D., Weissberg, P., Arch, B., Scott, J. (2004). Prehospital thrombolysis--calculated health benefit for catchment population of one hospital. JRSM 97: 230-234 [Abstract] [Full Text]  
• Steg, P. G., Bonnefoy, E., Chabaud, S., Lapostolle, F., Dubien, P.-Y., Cristofini, P., Leizorovicz, A., Touboul, P., for the Comparison of Angioplasty and Prehospital, (2003). Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial. Circulation 108: 2851-2856 [Abstract] [Full Text]  
• Wallentin, L., Goldstein, P., Armstrong, P.W., Granger, C.B., Adgey, A.A.J., Arntz, H.R., Bogaerts, K., Danays, T., Lindahl, B., Makijarvi, M., Verheugt, F., Van de Werf, F. (2003). Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction. Circulation 108: 135-142 [Abstract] [Full Text]  
• Pedley, D. K, Bissett, K., Connolly, E. M, Goodman, C. G, Golding, I., Pringle, T H, McNeill, G P, Pringle, S D, Jones, M C (2003). Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics. BMJ 327: 22-26 [Abstract] [Full Text]  
• Terkelsen, C J, Lassen, J F, Norgaard, B L, Gerdes, J C, Nielsen, T T, Andersen, H R (2003). Are we underestimating the full potential of early thrombolytic treatment in patients with acute myocardial infarction?. Heart 89: 483-484 [Abstract] [Full Text]  
• Mathew, T.P., Menown, I.B.A., McCarty, D., Gracey, H., Hill, L., Adgey, A.A.J. (2003). Impact of pre-hospital care in patients with acute myocardial infarction compared with those first managed in-hospital. Eur Heart J 24: 161-171 [Abstract] [Full Text]  
• The Task Force on the Management of Acute Myocardi, , Van de Werf, F., Ardissino, D., Betriu, A., Cokkinos, D. V., Falk, E., Fox, K. A.A., Julian, D., Lengyel, M., Neumann, F.-J., Ruzyllo, W., Thygesen, C., Underwood, S. R., Vahanian, A., Verheugt, F. W.A., Wijns, W. (2003). Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 24: 28-66 [Full Text]  
• Benger, J R, Karlsten, R, Eriksson, B (2002). Prehospital thrombolysis: lessons from Sweden and their application to the United Kingdom. Emerg. Med. J. 19: 578-583 [Abstract] [Full Text]  
• Stephenson, D T, Wardrope, J W, Goodacre, S W (2002). Is prehospital thrombolysis for acute myocardial infarction warranted in the urban setting? The case against. Emerg. Med. J. 19: 444-447 [Abstract] [Full Text]  
• Erhardt, L., Herlitz, J., Bossaert, L., Halinen, M., Keltai, M., Koster, R., Marcassa, C., Quinn, T., van Weert, H. (2002). Task force on the management of chest pain. Eur Heart J 23: 1153-1176 [Full Text]  
• Selker, H. P., Beshansky, J. R., Griffith, J. L., for the TPI Trial Investigators*, (2002). Use of the Electrocardiograph-Based Thrombolytic Predictive Instrument To Assist Thrombolytic and Reperfusion Therapy for Acute Myocardial Infarction: A Multicenter, Randomized, Controlled, Clinical Effectiveness Trial. ANN INTERN MED 137: 87-95 [Abstract] [Full Text]  
• Morrow, D. A., Antman, E. M., Sayah, A., Schuhwerk, K. C., Giugliano, R. P., deLemos, J. A., Waller, M., Cohen, S. A., Rosenberg, D. G., Cutler, S. S., McCabe, C. H., Walls, R. M., Braunwald, E., Early Retavase-Thrombolysis In Myocardial Infarcti, (2002). Evaluation of the time saved byprehospital initiation of reteplase forST-elevation myocardial infarction: Results of the early retavase-thrombolysisin myocardial infarction (ER-TIMI) 19 trial. J Am Coll Cardiol 40: 71-77 [Abstract] [Full Text]  
• Braunwald, E. (2002). Reperfusion therapy for acute myocardial infarction: historical context and future promise. Eur Heart J Suppl 4: E10-E14 [Abstract]  
• Estess, J M, Topol, E J (2002). Fibrinolytic treatment for elderly patients with acute myocardial infarction. Heart 87: 308-311 [Full Text]  
• Gershlick, A H (2001). The acute management of myocardial infarction. Br Med Bull 59: 89-112 [Abstract] [Full Text]  
• Cannon, C. P. (2001). Importance of TIMI 3 Flow. Circulation 104: 624-626 [Full Text]  
• Llevadot, J., Giugliano, R. P., Antman, E. M. (2001). Bolus Fibrinolytic Therapy in Acute Myocardial Infarction. JAMA 286: 442-449 [Abstract] [Full Text]  
• Loubeyre, C, Lefevre, T, Louvard, Y, Dumas, P, Piechaud, J.-F, Lanore, J.-J, Angellier, J.-F, Le Tarnec, J.-Y, Karrillon, G, Margenet, A, Pouges, C, Morice, M.-C (2001). Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J 22: 1128-1135 [Abstract]  
• Ohman, E. M., Harrington, R. A., Cannon, C. P., Agnelli, G., Cairns, J. A., Kennedy, J.W. (2001). Intravenous Thrombolysis in Acute Myocardial Infarction. Chest 119: 253S-277S [Full Text]  
• Sayer, J W, Archbold, R A, Wilkinson, P, Ray, S, Ranjadayalan, K, Timmis, A D (2000). Prognostic implications of ventricular fibrillation in acute myocardial infarction: new strategies required for further mortality reduction. Heart 84: 258-261 [Abstract] [Full Text]  
• Morrison, L. J., Verbeek, P. R., McDonald, A. C., Sawadsky, B. V., Cook, D. J. (2000). Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction: A Meta-analysis. JAMA 283: 2686-2692 [Abstract] [Full Text]  
• Ewy, G. A., Ornato, J. P. (2000). Emergency cardiac care: introduction. J Am Coll Cardiol 35: 825-880 [Full Text]  
• Birkhead, J S (1999). Trends in the provision of thrombolytic treatment between 1993 and 1997. Heart 82: 438-442 [Abstract] [Full Text]  
• Thiemann, D. R., Coresh, J., Oetgen, W. J., Powe, N. R. (1999). The Association between Hospital Volume and Survival after Acute Myocardial Infarction in Elderly Patients. NEJM 340: 1640-1648 [Abstract] [Full Text]  
• Danchin, N., Vaur, L., Genes, N., Etienne, S., Angioi, M., Ferrieres, J., Cambou, J.-P. (1999). Treatment of Acute Myocardial Infarction by Primary Coronary Angioplasty or Intravenous Thrombolysis in the "Real World" : One-Year Results From a Nationwide French Survey. Circulation 99: 2639-2644 [Abstract] [Full Text]  
• Cannon, C. P., Gibson, C. M., McCabe, C. H., Adgey, A. A. J., Schweiger, M. J., Sequeira, R. F., Grollier, G., Giugliano, R. P., Frey, M., Mueller, H. S., Steingart, R. M., Weaver, W. D., Van de Werf, F., Braunwald, E. (1998). TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction : Results of the TIMI 10B Trial. Circulation 98: 2805-2814 [Abstract] [Full Text]  
• (1998). Effect of time from onset to coming under care on fatality of patients with acute myocardial infarction: effect of resuscitation and thrombolytic treatment. Heart 80: 114-120 [Abstract] [Full Text]  
• White, H. D., Van de Werf, F. J. J. (1998). Thrombolysis for Acute Myocardial Infarction. Circulation 97: 1632-1646 [Abstract] [Full Text]  
• Collins, R., Peto, R., Baigent, C., Sleight, P. (1997). Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction. NEJM 336: 847-860 [Full Text]  
• Cannon, C. P., McCabe, C. H., Gibson, C. M., Ghali, M., Sequeira, R. F., McKendall, G. R., Breed, J., Modi, N. B., Fox, N. L., Tracy, R. P., Love, T. W., Braunwald, E. (1997). TNK-Tissue Plasminogen Activator in Acute Myocardial Infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A Dose-Ranging Trial. Circulation 95: 351-356 [Abstract] [Full Text]  
• Leizorovicz, A. (1996). Benefit from earlier thrombolytic therapy is certain, but what is the magnitude of benefit?. BMJ 312: 215-216 [Full Text]  
• Raitt, M. H., Maynard, C., Wagner, G. S., Cerqueira, M. D., Selvester, R. H., Weaver, W. D. (1996). Relation Between Symptom Duration Before Thrombolytic Therapy and Final Myocardial Infarct Size. Circulation 93: 48-53 [Abstract] [Full Text]  
• Laperche, T., Steg, P. G., Dehoux, M., Benessiano, J., Grollier, G., Aliot, E., Mossard, J.-M., Aubry, P., Coisne, D., Hanssen, M., Iliou, M.-C. (1995). A Study of Biochemical Markers of Reperfusion Early After Thrombolysis for Acute Myocardial Infarction. Circulation 92: 2079-2086 [Abstract] [Full Text]  
• Simes, R.J., Topol, E. J., Holmes, D. R. Jr, White, H. D., Rutsch, W. R., Vahanian, A., Simoons, M. L., Morris, D., Betriu, A., Califf, R. M., Ross, A. M. (1995). Link Between the Angiographic Substudy and Mortality Outcomes in a Large Randomized Trial of Myocardial Reperfusion : Importance of Early and Complete Infarct Artery Reperfusion. Circulation 91: 1923-1928 [Abstract] [Full Text]  
• Grech, E. D, Jackson, M. J, Ramsdale, D. R (1995). Reperfusion injury after acute myocardial infarction. BMJ 310: 477-478 [Full Text]  
• Rawles, J. (1995). Treatment of myocardial infarction and angina. BMJ 310: 465a-465 [Full Text]  
• McMurray, J, Rankin, A (1994). Recent Advances: Cardiology - I: Treatment of myocardial infarction, unstable angina, and angina pectoris. BMJ 309: 1343-1350 [Full Text]  
• (1994). Should general practitioners give thrombolytic therapy?. DTB 32: 65-66 [Abstract] [Full Text]  
• Rawles, J (1994). Attitudes of general practitioners to prehospital thrombolysis. BMJ 309: 379-379 [Abstract] [Full Text]  
• Weston, C F M, Penny, W J, Julian, D G (1994). Guidelines for the early management of patients with myocardial infarction. BMJ 308: 767-771 [Full Text]  
• Fath-Ordoubadi, F., Solomon, S. D., Antman, E. (1994). Prehospital Thrombolytic Therapy for Myocardial Infarction. NEJM 330: 290-291 [Full Text]  
• Cobbe, S M (1994). Thrombolysis in myocardial infarction. BMJ 308: 216-217 [Full Text]  
• (1993). PREHOSPITAL THROMBOLYSIS IS SAFE AND PROBABLY BENEFICIAL. JWatch General 1993: 3-3 [Full Text]